New pain block technique could slash opioid use after jaw surgery
NCT ID NCT05351151
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested whether ultrasound-guided nerve blocks in the jaw could reduce pain and opioid use after maxillomandibular osteotomy (jaw realignment surgery). Fifty patients aged 15 to 45 were enrolled. One group received nerve blocks with ropivacaine, while the other had standard lidocaine injections at incision sites. The main goal was to measure opioid consumption in the first 24 hours after surgery.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Ropivacaine and Lidocaine (local anesthetics)
What this could lead to
If effective, this approach could reduce the need for strong painkillers like opioids after jaw surgery, leading to fewer side effects and faster recovery.
What could go wrong
This is a small, completed study with only 50 participants. The results may not apply to all patients or surgeries, and nerve blocks carry risks like infection or nerve damage.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for REGIONAL ANESTHESIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University Hospital of Toulouse
Toulouse, 31100, France